Instructions for finding a CME article.
Investigating mono vs dual therapy for pediatric pulmonary arterial hypertension
Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial assessing mono vs dual therapy for pediatric PAH.
Food Insecurity and the Dangers of Infant Formula Dilution
PDUFA date set for neffy 1 mg for children who weigh 33 lbs or more
Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg).
Demystifying Infant Formula
Addictive behaviors surrounding social media could lead to binge eating
Results from a recent study revealed that compulsive and addictive elements can contribute to the risk of disordered eating. Study investigator Susan Carnell, PhD, explains these findings.
Data: 80% of INZ-701-treated infants with ENPP1 Deficiency survived past first year
Positive interim data was reported from the ENERGY 1 trial and Expanded Access Program that featured a total of 5 infants and 1 child.
